CA2304119A1 - Modulation of immune responses - Google Patents
Modulation of immune responses Download PDFInfo
- Publication number
- CA2304119A1 CA2304119A1 CA002304119A CA2304119A CA2304119A1 CA 2304119 A1 CA2304119 A1 CA 2304119A1 CA 002304119 A CA002304119 A CA 002304119A CA 2304119 A CA2304119 A CA 2304119A CA 2304119 A1 CA2304119 A1 CA 2304119A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- immune
- animal
- alkyl
- alkenyl groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA97/8319 | 1997-09-16 | ||
ZA978319 | 1997-09-16 | ||
PCT/US1998/019126 WO1999013885A1 (en) | 1997-09-16 | 1998-09-16 | Modulation of immune responses |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2304119A1 true CA2304119A1 (en) | 1999-03-25 |
Family
ID=25586589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002304119A Abandoned CA2304119A1 (en) | 1997-09-16 | 1998-09-16 | Modulation of immune responses |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1019063A4 (xx) |
JP (1) | JP2001516721A (xx) |
CN (1) | CN1279612A (xx) |
AU (1) | AU737867B2 (xx) |
BR (1) | BR9812321A (xx) |
CA (1) | CA2304119A1 (xx) |
IL (1) | IL135091A0 (xx) |
NO (1) | NO20001341L (xx) |
NZ (1) | NZ503418A (xx) |
WO (1) | WO1999013885A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2324631A1 (en) * | 2000-10-26 | 2002-04-26 | Virodene Pharmaceutical Holdings (Proprietary) Limited | A substance or composition for the treatment of cancer |
WO2005053641A1 (en) * | 2003-12-05 | 2005-06-16 | Namibia Medical Investments (Pty) Limited | Patch |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814659A (en) * | 1996-04-23 | 1998-09-29 | Dtr Dermal Therapy (Barbados) Inc. | Topical analgesic composition |
-
1998
- 1998-09-16 CA CA002304119A patent/CA2304119A1/en not_active Abandoned
- 1998-09-16 WO PCT/US1998/019126 patent/WO1999013885A1/en not_active Application Discontinuation
- 1998-09-16 AU AU93890/98A patent/AU737867B2/en not_active Ceased
- 1998-09-16 NZ NZ503418A patent/NZ503418A/xx not_active IP Right Cessation
- 1998-09-16 JP JP2000511505A patent/JP2001516721A/ja active Pending
- 1998-09-16 CN CN98810397A patent/CN1279612A/zh active Pending
- 1998-09-16 BR BR9812321-1A patent/BR9812321A/pt not_active IP Right Cessation
- 1998-09-16 EP EP98946998A patent/EP1019063A4/en not_active Withdrawn
- 1998-09-16 IL IL13509198A patent/IL135091A0/xx unknown
-
2000
- 2000-03-15 NO NO20001341A patent/NO20001341L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1279612A (zh) | 2001-01-10 |
WO1999013885A1 (en) | 1999-03-25 |
NZ503418A (en) | 2001-02-23 |
JP2001516721A (ja) | 2001-10-02 |
EP1019063A1 (en) | 2000-07-19 |
AU737867B2 (en) | 2001-09-06 |
IL135091A0 (en) | 2001-05-20 |
EP1019063A4 (en) | 2003-09-03 |
NO20001341D0 (no) | 2000-03-15 |
NO20001341L (no) | 2000-05-16 |
AU9389098A (en) | 1999-04-05 |
BR9812321A (pt) | 2000-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaufman | Clinical cure of herpes simplex keratitis by 5-iodo-2'-deoxyuridine | |
Porozov et al. | Inhibition of IL‐1β and TNF‐α Secretion from Resting and Activated Human Immunocytes by the Homeopathic Medication Traumeel® S | |
TW438588B (en) | Topical ophthalmic formulations for treating allergic eye diseases | |
ES2240163T3 (es) | Utilizaciones terapeuticas de polimeros y de oligomeros a base de gamma-hidroxibutirano (ghb). | |
Wu et al. | Recombinant osteopontin attenuates brain injury after intracerebral hemorrhage in mice | |
Li et al. | Contribution of the P2X4 receptor in rat hippocampus to the comorbidity of chronic pain and depression | |
Palin et al. | The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFα-induced sickness behavior | |
Olianas et al. | Inhibition of TNF-α-induced neuronal apoptosis by antidepressants acting through the lysophosphatidic acid receptor LPA1 | |
Kusher et al. | Effect of the psychoactive metabolite of marijuana, Δ9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes | |
JPH11504050A (ja) | 生物学的応答修飾因子としての双性イオンの組成物及び方法 | |
Constantin et al. | Sulfatides trigger cytokine gene expression and secretion in human monocytes | |
AU737867B2 (en) | Modulation of immune responses | |
Nathanson et al. | Diffusion of Sulfonamides and Penicillin into Fibrin. | |
Quan et al. | Aquaporins in Immune System | |
Klein et al. | Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice | |
CN101701218B (zh) | 一种抑制Th1和Th17分化的免疫调节性寡聚脱氧核苷酸及应用 | |
Chang | Mechanism of action of colchicine. II. Effects of colchicine and its analogs on phagocytosis and chemotaxis in vitro. | |
CN1329497A (zh) | 对乙型肝炎病毒的联合治疗 | |
Meyler et al. | The effect of dantrolene sodium in relation to blood levels in spastic patients after prolonged administration. | |
Mondino et al. | Complement inhibitors in normal cornea and aqueous humor. | |
CN105311636B (zh) | 一种抗疱疹病毒软膏剂及其制备方法 | |
ES2281195T3 (es) | Factores inmunomoduladores para el tratamiento inmunosupresor y antialergico. | |
US11944601B2 (en) | Applications of ellagic acid in preparation of immunomodulatory medicines for treatment of neuromyelitis optica or immune rejection after skin transplantation | |
WO2014191822A1 (en) | BENZOIC ACID DERIVATIVES AS IL-15Rα RECEPTOR INHIBITORS | |
RU2008902C1 (ru) | Способ лечения туберкулеза легких с преимущественно экссудативным типом воспаления |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |